0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Molecular and Clinical Advances in Anticancer Drug Resistance (Hardcover, 1991 ed.) Loot Price: R5,612
Discovery Miles 56 120
Molecular and Clinical Advances in Anticancer Drug Resistance (Hardcover, 1991 ed.): Robert F. Ozols

Molecular and Clinical Advances in Anticancer Drug Resistance (Hardcover, 1991 ed.)

Robert F. Ozols

Series: Cancer Treatment and Research, 57

 (sign in to rate)
Loot Price R5,612 Discovery Miles 56 120 | Repayment Terms: R526 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

The importance of drug resistance in cancer chemotherapy cannot be over stated. The 500,000 patients who die every year from cancer in the United States have, in most cases, been treated with chemotherapy. Many of these patients responded initially to chemotherapy, but death resulted from the development of drug-resistant tumors. In the first volume in the series. Drug Resistance in Chemotherapy the results of comprehensive laboratory studies aimed at understanding the mechanisms for resistance to individual agents and to the development of broad cross-resistance were described. In the past 2 years there has been substantial progress in understanding the molecular biology associated with these mechanisms of drug resistance. For the first time we are starting to understand which mechanisms are playing an im portant role in human tumors, and even more importantly, clinical trials have recently been initiated in an effort to reverse specific forms of drug resistance. The purpose of this volume is to describe the new advances, both at the molecular level and in the clinic regarding mechanisms of drug resistance and potential ways this resistance can be circumvented. This volume is focused upon mechanisms of resistance associated with two major classes of anticancer drugs: alkylating agents (including cisplatin) and the natural products (e. g., adriamycin and vinblastine). The first section of the book describes new insights into the genetic mechanisms associated with drug resistance."

General

Imprint: Springer
Country of origin: Netherlands
Series: Cancer Treatment and Research, 57
Release date: September 1991
First published: September 1991
Editors: Robert F. Ozols
Dimensions: 235 x 155 x 19mm (L x W x T)
Format: Hardcover
Pages: 308
Edition: 1991 ed.
ISBN-13: 978-0-7923-1212-3
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 0-7923-1212-0
Barcode: 9780792312123

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners